The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Corticosteroid Injections for Joint Pain Market Research Report 2024
Synopsis
Corticosteroid Injections products used for Joint Pain.
The global Corticosteroid Injections for Joint Pain market was valued at US$ 2145 million in 2023 and is anticipated to reach US$ 3244 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Corticosteroid Injections for Joint Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Injections for Joint Pain.
Report Scope
The Corticosteroid Injections for Joint Pain market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Corticosteroid Injections for Joint Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Corticosteroid Injections for Joint Pain manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma
Segment by Type
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Corticosteroid Injections for Joint Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Corticosteroid Injections for Joint Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Corticosteroid Injections products used for Joint Pain.
The global Corticosteroid Injections for Joint Pain market was valued at US$ 2145 million in 2023 and is anticipated to reach US$ 3244 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Corticosteroid Injections for Joint Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Injections for Joint Pain.
Report Scope
The Corticosteroid Injections for Joint Pain market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Corticosteroid Injections for Joint Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Corticosteroid Injections for Joint Pain manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma
Segment by Type
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Corticosteroid Injections for Joint Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Corticosteroid Injections for Joint Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Corticosteroid Injections for Joint Pain Market Overview
1.1 Product Overview and Scope of Corticosteroid Injections for Joint Pain
1.2 Corticosteroid Injections for Joint Pain Segment by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024-2030)
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Corticosteroid Injections for Joint Pain Segment by Application
1.3.1 Global Corticosteroid Injections for Joint Pain Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Corticosteroid Injections for Joint Pain Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Injections for Joint Pain Revenue 2019-2030
1.4.2 Global Corticosteroid Injections for Joint Pain Sales 2019-2030
1.4.3 Global Corticosteroid Injections for Joint Pain Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Corticosteroid Injections for Joint Pain Market Competition by Manufacturers
2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2019-2024)
2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Corticosteroid Injections for Joint Pain Average Price by Manufacturers (2019-2024)
2.4 Global Corticosteroid Injections for Joint Pain Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Product Type & Application
2.7 Corticosteroid Injections for Joint Pain Market Competitive Situation and Trends
2.7.1 Corticosteroid Injections for Joint Pain Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue
2.7.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Corticosteroid Injections for Joint Pain Retrospective Market Scenario by Region
3.1 Global Corticosteroid Injections for Joint Pain Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Corticosteroid Injections for Joint Pain Global Corticosteroid Injections for Joint Pain Sales by Region: 2019-2030
3.2.1 Global Corticosteroid Injections for Joint Pain Sales by Region: 2019-2024
3.2.2 Global Corticosteroid Injections for Joint Pain Sales by Region: 2025-2030
3.3 Global Corticosteroid Injections for Joint Pain Global Corticosteroid Injections for Joint Pain Revenue by Region: 2019-2030
3.3.1 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2019-2024
3.3.2 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2025-2030
3.4 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.4.1 North America Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)
3.4.3 North America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.5.1 Europe Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)
3.5.3 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.6.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)
3.6.3 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.7.1 Latin America Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)
3.7.3 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.8.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)
3.8.3 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2019-2030)
4.1.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2019-2024)
4.1.2 Global Corticosteroid Injections for Joint Pain Sales by Type (2025-2030)
4.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2019-2030)
4.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2019-2030)
4.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Type (2019-2024)
4.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2025-2030)
4.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2019-2030)
4.3 Global Corticosteroid Injections for Joint Pain Price by Type (2019-2030)
5 Segment by Application
5.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2019-2030)
5.1.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2019-2024)
5.1.2 Global Corticosteroid Injections for Joint Pain Sales by Application (2025-2030)
5.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2019-2030)
5.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2019-2030)
5.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Application (2019-2024)
5.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2025-2030)
5.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2019-2030)
5.3 Global Corticosteroid Injections for Joint Pain Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Corticosteroid Injections for Joint Pain Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Ferring
6.5.1 Ferring Corporation Information
6.5.2 Ferring Description and Business Overview
6.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ferring Corticosteroid Injections for Joint Pain Product Portfolio
6.5.5 Ferring Recent Developments/Updates
6.6 Bioventus
6.6.1 Bioventus Corporation Information
6.6.2 Bioventus Description and Business Overview
6.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Portfolio
6.6.5 Bioventus Recent Developments/Updates
6.7 Flexion Therapeutics
6.6.1 Flexion Therapeutics Corporation Information
6.6.2 Flexion Therapeutics Description and Business Overview
6.6.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates
6.8 Zimmer Biomet
6.8.1 Zimmer Biomet Corporation Information
6.8.2 Zimmer Biomet Description and Business Overview
6.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio
6.8.5 Zimmer Biomet Recent Developments/Updates
6.9 SEIKAGAKU
6.9.1 SEIKAGAKU Corporation Information
6.9.2 SEIKAGAKU Description and Business Overview
6.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio
6.9.5 SEIKAGAKU Recent Developments/Updates
6.10 Chugai Pharma
6.10.1 Chugai Pharma Corporation Information
6.10.2 Chugai Pharma Description and Business Overview
6.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio
6.10.5 Chugai Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis
7.2 Corticosteroid Injections for Joint Pain Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Corticosteroid Injections for Joint Pain Production Mode & Process
7.4 Corticosteroid Injections for Joint Pain Sales and Marketing
7.4.1 Corticosteroid Injections for Joint Pain Sales Channels
7.4.2 Corticosteroid Injections for Joint Pain Distributors
7.5 Corticosteroid Injections for Joint Pain Customers
8 Corticosteroid Injections for Joint Pain Market Dynamics
8.1 Corticosteroid Injections for Joint Pain Industry Trends
8.2 Corticosteroid Injections for Joint Pain Market Drivers
8.3 Corticosteroid Injections for Joint Pain Market Challenges
8.4 Corticosteroid Injections for Joint Pain Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
